Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort
- PMID: 31918830
- PMCID: PMC7043927
- DOI: 10.1016/j.jacc.2019.10.048
Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort
Abstract
Background: Abnormal pulmonary arterial pressure (PAP) responses to exercise have been described in select individuals; however, clinical and prognostic implications of exercise pulmonary hypertension (exPH) among broader samples remains unclear.
Objectives: This study sought to investigate the association of exPH with clinical determinants and outcomes.
Methods: The authors studied individuals with chronic exertional dyspnea and preserved ejection fraction who underwent cardiopulmonary exercise testing with invasive hemodynamic monitoring. Exercise pulmonary hypertension was ascertained using minute-by-minute PAP and cardiac output (CO) measurements to calculate a PAP/CO slope, and exPH defined as a PAP/CO slope >3 mm Hg/l/min. The primary outcome was cardiovascular (CV) hospitalization or all-cause mortality.
Results: Among 714 individuals (age 57 years, 59% women), 296 (41%) had abnormal PAP/CO slopes. Over a mean follow-up of 3.7 ± 2.9 years, there were 208 CV or death events. Individuals with abnormal PAP/CO slope had a 2-fold increased hazard of future CV or death event (multivariable-adjusted hazard ratio: 2.03; 95% confidence interval: 1.48 to 2.78; p < 0.001). The association of abnormal PAP/CO slope with outcomes remained significant after excluding rest PH (n = 146, hazard ratio: 1.75; 95% confidence interval: 1.21 to 2.54; p = 0.003). Both pre- and post-capillary contributions to exPH independently predicted adverse events (p < 0.001 for both).
Conclusions: Exercise pulmonary hypertension is independently associated with CV event-free survival among individuals undergoing evaluation of chronic dyspnea. These findings suggest incremental value of exercise hemodynamic assessment to resting measurements alone in characterizing the burden of PH in individuals with dyspnea. Whether PH and PH subtypes unmasked by exercise can be used to guide targeted therapeutic interventions requires further investigation.
Keywords: cardiovascular disease; exercise; pulmonary hypertension.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures


Comment in
-
Exercise Pulmonary Hypertension Is Back.J Am Coll Cardiol. 2020 Jan 7;75(1):27-28. doi: 10.1016/j.jacc.2019.11.010. J Am Coll Cardiol. 2020. PMID: 31918831 No abstract available.
-
Does PAP/CO Ratio Have a Linear Relationship?J Am Coll Cardiol. 2020 May 26;75(20):2646. doi: 10.1016/j.jacc.2020.02.071. J Am Coll Cardiol. 2020. PMID: 32439016 No abstract available.
-
Reply: Does PAP/CO Ratio Have a Linear Relationship?J Am Coll Cardiol. 2020 May 26;75(20):2647. doi: 10.1016/j.jacc.2020.03.050. J Am Coll Cardiol. 2020. PMID: 32439017 No abstract available.
-
Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling.Am J Respir Crit Care Med. 2022 Jun 1;205(11):1349. doi: 10.1164/rccm.202107-1611RR. Am J Respir Crit Care Med. 2022. PMID: 35333146 No abstract available.
References
-
- Simonneau G, Galiè N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12S. - PubMed
-
- Fishman AP. Pulmonary circulation. Handbook of physiology The Respiratory system Circulation and nonrespiratory functions. 1985;1:93–166.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials